MPD: Project measures / variables set: Graham1 WNV

Project measures / variables set: Graham1 WNV_IgM

ID, description, units	MPD:63361 WNV_IgM virus-specific IgM in serum, post infection [ng/mL] West Nile virus study
Measures	• day 7 • day 12 • day 21 • day 28
Data set, strains	Graham1 CC RIX 5 strains sex: m age: 8-10wks
Procedure	immunoglobulin quantification
Comparison	timecourse but different cohorts
Ontology mappings	VT:0010439 response to viral infection trait VT:0010481 blood immunoglobulin M amount MA:0002502 serum MP:0020180 abnormal IgM level MP:0020185 altered susceptibility to viral infection

Values Means Δ Means Z-scores

Graph Type Points Bars

Dimensions Width: × Height: px

Plot Options Hide Error Bars Strains on X-axis

Data Type:

Dimensions Height: px

Toggle Series

Plot Options Show Standard Error Show Point Labels Flip Axes Shared Tooltip Connect Gaps

Graham1 - virus-specific IgM in serum, post infection

ANOVA Summary

Factor	DF	Sum of squares	Mean sum of squares	F value	p-value (Pr>F)
group	3	4867.0332	1622.3444	20.0737	< 0.0001
group:strain	6	667.9718	111.3286	1.3775	0.2654
Residuals	23	1858.8458	80.8194
strain	2	754.1641	377.0821	4.6657	0.0199

Q-Q normality assessment based on residuals

INDIVIDUAL MEASURES

Project	ID		Treatment	Measure / Variable Description	Panel	Strains tested	Sex	Age
Graham1	63361	immunoglobulin quantification	West Nile virus	virus-specific IgM in serum, post infection [ng/mL] day 7 WNV_IgM_d7	CC RIX	5	m	8-10wks
Graham1	63362	immunoglobulin quantification	West Nile virus	virus-specific IgM in serum, post infection [ng/mL] day 12 WNV_IgM_d12	CC RIX	5	m	8-10wks
Graham1	63363	immunoglobulin quantification	West Nile virus	virus-specific IgM in serum, post infection [ng/mL] day 21 WNV_IgM_d21	CC RIX	4	m	8-10wks
Graham1	63364	immunoglobulin quantification	West Nile virus	virus-specific IgM in serum, post infection [ng/mL] day 28 WNV_IgM_d28	CC RIX	5	m	8-10wks